Clinical Trial Update: Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating hypofractionated radiotherapy as primary therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED